文献速递其他结缔组织病

新型自身抗体有助于诊断抗SSA抗体阴性的干燥病并预测唇腺病理异常

Novel autoantibodies help diagnose anti-SSA antibody negative Sjögren disease and predict abnormal labial salivary gland pathology.
PubMed 文献 · Ann Rheum Dis · 2024-08-27

本研究利用高密度全人类肽库阵列,在抗SSA抗体阴性的干燥病患者中寻找新型自身抗体,并在独立队列中验证。结果显示抗DTD2肽段IgG在抗SSA抗体阴性干燥病患者中结合高于干燥对照和合并对照,且抗逆转录元件沉默因子-1和DTD2肽段IgG在焦点评分阳性者中结合更高。结合临床变量的预测模型对干燥病与对照的区分(AUC 74%)及焦点评分阳性与阴性的区分(AUC 72%)均显示良好判别能力。

要点

  • 抗DTD2肽段IgG在抗SSA抗体阴性干燥病患者中结合高于干燥对照(p=0.004)及合并对照(p=0.003)。
  • 抗逆转录元件沉默因子-1和DTD2肽段IgG在焦点评分阳性者中结合高于阴性者(p=0.010;p=0.012)。
  • 结合临床变量的预测模型区分干燥病与对照的AUC为74%,区分焦点评分阳性与阴性的AUC为72%。

核心结论

  • 在抗SSA抗体阴性的干燥病患者中发现了新型自身抗体,这些抗体对诊断抗SSA抗体阴性干燥病和预测焦点评分阳性具有良好预测价值。

研究设计与样本

  • 研究采用高密度全人类肽库阵列定量血清IgG结合,先用抗SSA抗体阴性干燥病病例和匹配的非自身免疫对照筛选最高结合肽段,再在独立队列中验证,该队列包括抗SSA抗体阴性干燥病患者76例、无自身免疫的干燥对照75例和有自身免疫特征但不符合干燥病标准的对照41例。
  • 外部验证中使用非参数方法分析结合丰度,并在组间比较中控制错误发现率;预测建模采用逻辑回归、模型选择方法和交叉验证来筛选预测抗SSA抗体阴性干燥病和焦点评分阳性的临床及肽段变量。

主要发现

  • 抗D-氨酰-tRNA脱酰酶(DTD2)肽段的IgG在抗SSA抗体阴性干燥病患者中的结合高于干燥对照(p=0.004),也高于合并对照(干燥对照和自身免疫特征对照合并;p=0.003)。
  • 抗逆转录元件沉默因子-1和DTD2肽段的IgG在焦点评分阳性参与者中的结合高于焦点评分阴性参与者(p=0.010;p=0.012)。
  • 结合临床变量的预测模型区分干燥病与对照的曲线下面积(AUC)为74%,区分焦点评分阳性与阴性的AUC为72%。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Sjögren disease (SjD) diagnosis often requires either positive anti-SSA antibodies or a labial salivary gland biopsy with a positive focus score (FS). One-third of patients with SjD lack anti-SSA antibodies (SSA-), requiring a positive FS for diagnosis. Our objective was to identify novel autoantibodies to diagnose 'seronegative' SjD. METHODS: IgG binding to a high-density whole human peptidome array was quantified using sera from SSA- SjD cases and matched non-autoimmune controls. We identified the highest bound peptides using empirical Bayesian statistical filters, which we confirmed in an independent cohort comprising SSA- SjD (n=76), sicca-controls without autoimmunity (n=75) and autoimmune-feature controls (SjD features but not meeting SjD criteria; n=41). In this external validation, we used non-parametric methods for binding abundance and controlled false discovery rate in group comparisons. For predictive modelling, we used logistic regression, model selection methods and cross-validation to identify clinical and peptide variables that predict SSA- SjD and FS positivity. RESULTS: IgG against a peptide from D-aminoacyl-tRNA deacylase (DTD2) bound more in SSA- SjD than sicca-controls (p=0.004) and combined controls (sicca-controls and autoimmune-feature controls combined; p=0.003). IgG against peptides from retroelement silencing factor-1 and DTD2 were bound more in FS-positive than FS-negative participants (p=0.010; p=0.012). A predictive model incorporating clinical variables showed good discrimination between SjD versus control (area under the curve (AUC) 74%) and between FS-positive versus FS-negative (AUC 72%). CONCLUSION: We present novel autoantibodies in SSA- SjD that have good predictive value for SSA- SjD and FS positivity.

来源:Ann Rheum Dis,查看原文。版权归原作者所有。

引用

  1. Parker M, Zheng Z, Lasarev MR, et al. Novel autoantibodies help diagnose anti-SSA antibody negative Sjögren disease and predict abnormal labial salivary gland pathology. Ann Rheum Dis. 2024. PMID: 38702176. doi:10.1136/ard-2023-224936

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。